SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-019370
Filing Date
2023-09-21
Accepted
2023-09-21 16:23:57
Documents
1
Period of Report
2023-09-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6592
  Complete submission text file 0000899243-23-019370.txt   9011
Mailing Address 2001 MARKET STREET SUITE 2500 PHILADELPHIA PA 19103
Business Address
Harwin Peter Evan (Reporting) CIK: 0001663607 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38541 | Film No.: 231269372

Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Dianthus Therapeutics, Inc. /DE/ (Issuer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 BARR HARBOR DRIVE SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE SUITE 400 WEST CONSHOHOCKEN PA 19428 267-262-5300
Fairmount Funds Management LLC (Reporting) CIK: 0001802528 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38541 | Film No.: 231269374

Mailing Address 2001 MARKET STREET, SUITE 2500 PHILADELPHIA PA 19103
Business Address
Kiselak Tomas (Reporting) CIK: 0001830177 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38541 | Film No.: 231269373